Research alert
This entire item is of approximately 300 words
  • Click here to read this item in full online now
  • Click here to subscribe to Biomedical Materials and immediately access all its archives
  • Click here to review the contents of the November 2006 issue of Biomedical Materials and download it online

  • Issue: November 2006, page: 10

    Tissue Engineering - Phase 1 trials begin of first biologically-active treatment to ameliorate acute vascular injury

    Enrolment is now going on in two Phase 1 clinical trials to evaluate the safety and feasibility of a novel allogeneic cell therapy product, called Vascugel.

    Read related items on:

          
  • Medical
  • Vascugel
  • Pervasis Therapeutics

  • International Newsletters ©
     
                                                 Advertising on this site | Privacy Policy | Contact